Issue
Alert me when new journal issues are available via or via
Masthead page IFC Full-Text PDF (33 KB)
Editorial Board page i Full-Text PDF (58 KB)
Contents pages ii-iv Full-Text PDF (49 KB)
News and Topics
Planned renal allograft transplantation after tumor excision: Increasing the availability of living-donor kidneys, 18 May 2009 Maxwell Meng, Jared M. Whitson pages 349-351 Full Text | Full-Text PDF (110 KB)
Review Article
Dilemmas in the treatment of urothelial cancers of the prostate, 25 April 2008 Dena L. Walsh, Sam S. Chang pages 352-357 Abstract | Full Text | Full-Text PDF (170 KB)
Original Articles
The failure of a nerve sparing template to improve urinary continence after radical prostatectomy: Attention to study design, 25 April 2008 David T. Tzou, Bruce L. Dalkin, Bea Anne Christopher, Haiyan Cui pages 358-362 Abstract | Full Text | Full-Text PDF (133 KB)
P-glycoprotein activity in renal clear cell carcinoma, 28 April 2008 Elena Soto-Vega, Carlos Arroyo, Yvonne Richaud-Patin, Mario García-Carrasco, Luis G. Vázquez-Lavista, Luis Llorente pages 363-366 Abstract | Full Text | Full-Text PDF (213 KB)
Anxiety and depression in patients with prostate cancer and other urogenital cancer: A longitudinal study, 28 April 2008 Andreas Hinz, Oliver Krauss, Jens-Uwe Stolzenburg, Thilo Schwalenberg, Dominik Michalski, Reinhold Schwarz pages 367-372 Abstract | Full Text | Full-Text PDF (272 KB)
Association of chromosomal locus 8q24 and risk of prostate cancer: A hospital-based study of German patients treated with brachytherapy, 14 July 2008 Andreas Meyer, Peter Schürmann, Maryam Ghahremani, Ertan Kocak, Maria-Jantje Brinkhaus, Michael Bremer, Johann H. Karstens, Jörn Hagemann, Stefan Machtens, Thilo Dörk pages 373-376 Abstract | Full Text | Full-Text PDF (132 KB)
Isoforms of hyaluronidases can be a predictor of a prostate cancer of good prognosis, 22 July 2008 Vanessa K. de Sá, Flávio C. Canavez, Iran A. Silva, Miguel Srougi, Katia R.M. Leite pages 377-381 Abstract | Full Text | Full-Text PDF (231 KB)
XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapy, 16 June 2008 Marcos B. Pinho, Fernanda Costas, João Sellos, Rodrigo Dienstmann, Patricia B. Andrade, Daniel Herchenhorn, Fábio Afonso Peixoto, Valdelice O. Santos, Isabele A. Small, Denise P. Guimarães, Carlos G. Ferreira pages 382-390 Abstract | Full Text | Full-Text PDF (526 KB)
Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model, 05 June 2008 Guru Sonpavde, Weiguo Jian, Hao Liu, Meng-Fen Wu, Steven S. Shen, Seth P. Lerner pages 391-399 Abstract | Full Text | Full-Text PDF (733 KB)
Differences in shotgun protein expression profile between superficial bladder transitional cell carcinoma and normal urothelium, 26 September 2008 Hai Tao Niu, Yi Bing Zhang, Hai Ping Jiang, Bo Cheng, Guang Sun, Yi Wang, Ya Jun E, De Quan Pang, Ji Wu Chang pages 400-406 Abstract | Full Text | Full-Text PDF (552 KB)
Adult cystic nephroma: A case report and a review of the literature, 16 June 2008 Baris Kuzgunbay, Tahsin Turunc, Filiz Bolat, Ferhat Kilinc pages 407-409 Abstract | Full Text | Full-Text PDF (446 KB)
Seminar Section Introduction
Outcomes and quality of care in urology Badrinath R. Konety page 410 Full Text | Full-Text PDF (69 KB)
Seminar Articles
Defining high quality health care Matthew R. Cooperberg, John D. Birkmeyer, Mark S. Litwin pages 411-416 Abstract | Full Text | Full-Text PDF (363 KB)
Do high-volume hospitals and surgeons provide better care in urologic oncology? James A. Eastham pages 417-421 Abstract | Full Text | Full-Text PDF (530 KB)
The critical limitations of volume-outcome analysis Lars Ellison pages 422-426 Abstract | Full Text | Full-Text PDF (598 KB)
Quality of care indicators for prostate cancer: Progress toward consensus David C. Miller, Christopher S. Saigal pages 427-434 Abstract | Full Text | Full-Text PDF (586 KB)
Candidate quality of care indicators for localized bladder cancer Matthew R. Cooperberg, Michael P. Porter, Badrinath R. Konety pages 435-442 Abstract | Full Text | Full-Text PDF (204 KB)
Understanding the relationship between health care quality and the renal mass Seth A. Strope, J. Stuart Wolf, Khaled S. Hafez, Rodney L. Dunn, John M. Hollingsworth, Scott M. Gilbert, Brent K. Hollenbeck pages 443-447 Abstract | Full Text | Full-Text PDF (155 KB)
Quality of care for testis cancer Philipp Dahm, Charles J. Rosser, James M. McKiernan pages 448-453 Abstract | Full Text | Full-Text PDF (177 KB)
Letters to Editor
Response to the article by J.E. Montie, Screen detected, low volume prostate cancer: The case for active treatment. Urol Oncol 2008;26:511–515. Laurence Klotz page 454 Full Text | Full-Text PDF (71 KB)
Reply James E. Montie page 454 Full Text | Full-Text PDF (71 KB)
Survey Section Editorial Board page 455 Full-Text PDF (37 KB)
Urologic Oncology Survey
Commentary on Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term follow-up of a randomized clinical trial: Thompson IM, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, Canby-Hagino E, and Crawford ED, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA Mark A. Ritter pages 456-457 Abstract | Full Text | Full-Text PDF (103 KB)
Commentary on Comparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate cancer: Burdick MJ, Reddy CA, Ulchaker J, Angermeier K, Altman A, Chehade N, Mahadevan A, Kupelian PA, Klein EA, and Ciezki JP, Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio, USA Mark A. Ritter pages 457-458 Abstract | Full Text | Full-Text PDF (84 KB)
Commentary on Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: The positive impact of adjuvant radiotherapy: Da Pozzo LF, Cozzarini C, Briganti A, Suardi N, Salonia A, Bertini R, Gallina A, Bianchi M, Fantini GV, Bolognesi A, Fazio F, Montorsi F, Rigatti P, Department of Urology, Vita-Salute University, Milan, Italy Alexander R. Gottschalk page 458 Abstract | Full Text | Full-Text PDF (72 KB)
Commentary on Prospective assessment of gastrointestinal and genitourinary toxicity of salvage radiotherapy for patients with prostate-specific antigen relapse or local recurrence after radical prostatectomy: Pearse M, Choo R, Danjoux C, Gardner S, Morton G, Szumacher E, Loblaw A, Cheung P, Department of Radiation Oncology, Auckland Hospital, Auckland, New Zealand Alexander R. Gottschalk page 459 Abstract | Full Text | Full-Text PDF (72 KB)
Commentary on Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): An open randomized phase III trial: Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, Lund JA, Tasdemir I, Hoyer M, Wiklund F, Fossa SD, Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden Alexander R. Gottschalk pages 459-460 Abstract | Full Text | Full-Text PDF (82 KB)
Commentary on The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette Guerin for non-muscle-invasive bladder cancer: Is immediate cystectomy always necessary? Wo JY, Shipley WU, Dahl DM, Coen JJ, Heney NM, Kaufman DS, Zietman AL, Harvard Radiation Oncology Program, and Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA Alexander R. Gottschalk page 460 Abstract | Full Text | Full-Text PDF (69 KB)
Commentary on Circulating microRNAs as stable blood-based markers for cancer detection: Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M, Divisions of Human Biology, Clinical Research, and Public Health Services, Fred Hutchinson Cancer Research Center, Seattle, WA Adam S. Kibel page 461 Abstract | Full Text | Full-Text PDF (70 KB)
Commentary on Transcriptome sequencing to detect gene fusions in cancer: Maher CA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S, Han B, Jing X, Sam L, Barrette T, Palanisamy N, Chinnaiyan AM, Michigan Center for Translational Pathology, Ann Arbor, MI Adam S. Kibel pages 461-462 Abstract | Full Text | Full-Text PDF (83 KB)
Commentary on Variation in KLK genes, prostate-specific antigen and risk of prostate cancer: Ahn J, Berndt SI, Wacholder S, Kraft P, Kibel AS, Yeager M, Albanes D, Giovannucci E, Stampfer MJ, Virtamo J, Thun MJ, Feigelson HS, Cancel-Tassin G, Cussenot O, Thomas G, Hunter DJ, Fraumeni JF Jr, Hoover RN, Chanock SJ, Hayes RB Adam S. Kibel page 462 Abstract | Full Text | Full-Text PDF (72 KB)
Commentary on Cumulative association of five genetic variants with prostate cancer: Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, Adami HO, Hsu FC, Zhu Y, Bälter K, Kader AK, Turner AR, Liu W, Bleecker ER, Meyers DA, Duggan D, Carpten JD, Chang BL, Isaacs WB, Xu J, Grönberg H, Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, NC Adam S. Kibel pages 462-463 Abstract | Full Text | Full-Text PDF (83 KB)
Commentary on Germline SDHB mutations and familial renal cell carcinoma: Ricketts C, Woodward ER, Killick P, Morris MR, Astuti D, Latif F, Maher ER, Cancer Research UK Renal Molecular Oncology Group, Department of Medical and Molecular Genetics, University of Birmingham School of Medicine, Edgbaston, Birmingham, UK Adam S. Kibel pages 463-464 Abstract | Full Text | Full-Text PDF (76 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
